Difficulty: Medium
Average Score: 91%
Practice
Medical treatment of myasthenia gravis includes:
Correct answer
C
Rationale
In the medical treatment of myasthenia gravis, the correct option is C) Edrophonium. Edrophonium is a short-acting acetylcholinesterase inhibitor used for diagnostic purposes in myasthenia gravis to differentiate between myasthenic crisis and cholinergic crisis. By temporarily increasing acetylcholine levels, edrophonium can improve muscle strength in myasthenia gravis patients.
Option A) Thymectomy is a surgical procedure that may be considered in some cases of myasthenia gravis, particularly if there is a thymoma present. However, it is not a medical treatment per se.
Option B) Physostigmine is another acetylcholinesterase inhibitor but is not commonly used in the treatment of myasthenia gravis due to its longer duration of action and potential for adverse effects.
Option D) Anticholinergic agents would exacerbate myasthenia gravis symptoms by further reducing acetylcholine activity at the neuromuscular junction, making it an inappropriate treatment choice for this condition.
In an educational context, understanding the pharmacological treatment options for myasthenia gravis is crucial for nursing students caring for pediatric patients with this condition. It is important to differentiate between the various medications available and their specific roles in managing the symptoms of myasthenia gravis to provide safe and effective care to these patients.
Option A) Thymectomy is a surgical procedure that may be considered in some cases of myasthenia gravis, particularly if there is a thymoma present. However, it is not a medical treatment per se.
Option B) Physostigmine is another acetylcholinesterase inhibitor but is not commonly used in the treatment of myasthenia gravis due to its longer duration of action and potential for adverse effects.
Option D) Anticholinergic agents would exacerbate myasthenia gravis symptoms by further reducing acetylcholine activity at the neuromuscular junction, making it an inappropriate treatment choice for this condition.
In an educational context, understanding the pharmacological treatment options for myasthenia gravis is crucial for nursing students caring for pediatric patients with this condition. It is important to differentiate between the various medications available and their specific roles in managing the symptoms of myasthenia gravis to provide safe and effective care to these patients.